The association between white blood cell count and outcomes in patients with idiopathic pulmonary fibrosis
Authors:
- Steven D. NathanSNSteven D. Nathan
- A. Whitney BrownABA. Whitney Brown
- Nesrin MogulkocNMNesrin Mogulkoc
- Flavia SoaresFSFlavia Soares
- Ashley C. CollinsACAshley C. Collins
- Joyce ChengJCJoyce Cheng
- Jake PetersonJPJake Peterson
- Brenna CannonBCBrenna Cannon
- Christopher S. KingCKChristopher S. King
- Scott D. BarnettSBScott D. Barnett
- 1 August 2020
- journal article
- research article
- Published by Elsevier in Respiratory Medicine
- Vol. 170
Abstract
No abstract availableKeywords
Funding Information
- Boerhinger-Ingelheim and Roche-Genentech
This publication has 24 references indexed in Scilit:
- Idiopathic Pulmonary FibrosisChest, 2016
- Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatmentsBMC Medicine, 2015
- An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis: An Update of the 2011 Clinical Practice GuidelineAmerican Journal of Respiratory and Critical Care Medicine, 2015
- Outcomes After Hospitalization in Idiopathic Pulmonary FibrosisChest, 2015
- Molecular biomarkers in idiopathic pulmonary fibrosisAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2014
- The Red Cell Distribution Width as a Prognostic Indicator in Idiopathic Pulmonary FibrosisChest, 2013
- Long-term Course and Prognosis of Idiopathic Pulmonary Fibrosis in the New MillenniumChest, 2011
- Clinical Course and Prediction of Survival in Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Novel cell death program leads to neutrophil extracellular trapsJournal of Cell Biology, 2007
- White Blood Cell Count Predicts Reduction in Coronary Heart Disease Mortality With PravastatinCirculation, 2005